GeekWire: 在报告令人失望的临床数据后， Eliem Therapeutics 的股价下跌了 50% 以上。在新的临床发现之后，另外两家最近上市的西雅图生物技术公司的价值也受到了影响。这里的故事：bit.ly/3MtHRGp #生物技术#西雅图科技

Posted on 2022-04-26

原推：Shares of Eliem Therapeutics fell more than 50% after reporting disappointing clinical data. The values of two other recently public Seattle biotech companies have also suffered in the wake of new clinical findings. Story here: bit.ly/3MtHRGp